Europe-Africa Research Network for Evaluation of Second-line Therapy
NCT00988039
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1277
Enrollment
OTHER_GOV
Sponsor class
Conditions
Human Immunodeficiency Virus
HIV
Interventions
DRUG:
Aluvia + 2NRTIs
DRUG:
Aluvia + raltegravir
DRUG:
Aluvia monotherapy
Sponsor
Justine Boles
Collaborators
[object Object]